Document Detail


Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.
MedLine Citation:
PMID:  21079532     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Vitamin D deficiency occurs more frequently in patients with primary hyperparathyroidism (PHPT) compared with the general population, and is usually associated with an aggravated form of the disease. Current guidelines recommend measurement of serum levels of 25-hydroxy vitamin D (25-OHD) in all patients with PHPT, and their repletion if the levels are less than 50 mmol/L (20 ng/mL). Limited data suggest that vitamin D treatment is generally safe in subjects with mild PHPT and coexisting vitamin D deficiency. Adverse effects include hypercalcuria and, less commonly, exacerbation of hypercalcemia. Well-designed trials are needed to evaluate the safety of vitamin D replacement therapy in a wide spectrum of patients with concomitant PHPT and vitamin D deficiency. These trials should address the impact of such therapy on the complications and course of PHPT.
Authors:
Nasser Mikhail
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  104     ISSN:  1541-8243     ISO Abbreviation:  South. Med. J.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  29-33     Citation Subset:  AIM; IM    
Affiliation:
Division of Endocrinology, Olive-View-UCLA Medical Center, Sylmar, CA 91342, USA. nmikhail@dhs.lacounty.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections
Comment In:
South Med J. 2011 Jan;104(1):5-6   [PMID:  21119552 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carboxyhemoglobin formation secondary to nitric oxide therapy in the setting of interstitial lung di...
Next Document:  Adenoid cystic carcinoma of trachea treated with tumor curettage and adjuvant intensity modulated ra...